February 27, 2026 · Form 4 insider transaction
Krishnan Suma sold 11,942 shares of Krystal Biotech, Inc. at $275.64 per share, a transaction worth $3.29M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish S. Krishnan.; Represents number of shares of common stock surrendered to the Company for tax withholding by the Reporting Person's spouse, Krish S. Krishnan, upon the vesting of 26,250 PSUs on February 27, 2026.; The closing price on February 27, 2026 of the Company's common stock on the Nasdaq Global Select Market.; Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person.